For help on how to get the results you want, see our search tips.
115 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Referrals Remove Referrals filter
Categories
Human Remove Human filter
-
List item
Referral: Pantoprazole Olinka (EMEA/H/A-29/1170)
pantoprazole, associated names: Pantecta, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/11/2009, EC decision date: 30/03/2010, Last updated: 08/03/2011 -
List item
Referral: Teicoplanin Hospira
teicoplanin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 22/10/2009, EC decision date: 29/01/2010, Last updated: 27/07/2010 -
List item
Referral: Loratadine Sandoz 10
loratadine 10 mg tablets, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 29/05/2009, EC decision date: 06/08/2009, Last updated: 12/12/2009 -
List item
Referral: Rapinyl
fentanyl citrate, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 26/06/2008, EC decision date: 11/09/2008, Last updated: 25/09/2009 -
List item
Referral: Prokanazol
itraconazole, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 23/04/2009, EC decision date: 14/07/2009, Last updated: 06/08/2009 -
List item
Referral: Octegra
moxifloxacin, Article 29(4) referrals
Status: Opinion provided by Committee for Medicinal Products for Human Use, opinion/position date: 19/03/2009, EC decision date: 02/10/2009, Last updated: 25/06/2009 -
List item
Referral: Budesonide Sandoz
budesonide, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/02/2009, EC decision date: 07/05/2009, Last updated: 25/06/2009 -
List item
Referral: Fentrix
fentanyl, Article 29(4) referrals
Status: Opinion provided by Committee for Medicinal Products for Human Use, opinion/position date: 25/06/2009, EC decision date: 06/10/2009, Last updated: 25/06/2009 -
List item
Referral: Gluscan 500
fludeoxyglucose (18F), Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/03/2009, EC decision date: 29/05/2009, Last updated: 23/06/2009 -
List item
Referral: Bleomycin
bleomycin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2008, EC decision date: 12/03/2009, Last updated: 31/03/2009 -
List item
Referral: Sanohex
salbutamol, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2008, EC decision date: 12/03/2009, Last updated: 30/03/2009 -
List item
Referral: Sabumalin
salbutamol, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2008, EC decision date: 12/03/2009, Last updated: 30/03/2009 -
List item
Referral: Uman Big
Human Hepatitis B Immunoglobulins, 180 IU/ml, solution for injection, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2008, EC decision date: 06/03/2009, Last updated: 21/03/2009 -
List item
Referral: Implanon
etonogestrel, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 21/11/2008, EC decision date: 06/02/2009, Last updated: 27/02/2009 -
List item
Referral: Trimetadizine-ratiopharm
trimetazidine, Article 29(4) referrals
Status: Opinion provided by Committee for Medicinal Products for Human Use, opinion/position date: 22/01/2009, Last updated: 22/01/2009 -
List item
Referral: Mephatrim
trimetazidine, Article 29(4) referrals
Status: Opinion provided by Committee for Medicinal Products for Human Use, opinion/position date: 22/01/2009, Last updated: 22/01/2009 -
List item
Referral: Lisonorm
lisinopril + amlodipine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/07/2008, EC decision date: 12/11/2008, Last updated: 18/12/2008 -
List item
Referral: Activelle
estradiol and norethisterone acetate, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 26/06/2008, EC decision date: 11/09/2008, Last updated: 25/09/2008 -
List item
Referral: Oracea
doxycycline monohydrate, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 24/04/2008, EC decision date: 22/07/2008, Last updated: 21/08/2008 -
List item
Referral: Alvesco
ciclesonide, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/03/2008, EC decision date: 11/07/2008, Last updated: 05/08/2008 -
List item
Referral: Menitorix
Haemophilus influenzae type b polysaccharide (polyribosyl ribitol phosphate) conjugated to tetanus toxoid and Neisseria meningitidis serogroup C (MenC) polysaccharide conjugated to tetanus toxoid, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 16/11/2007, EC decision date: 01/04/2008, Last updated: 18/04/2008 -
List item
Referral: Ciprofloxacin Nycomed
Ciprofloxacin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 17/11/2006, EC decision date: 18/01/2008, Last updated: 18/02/2008 -
List item
Referral: Xeomin
clostridium botulinum neurotoxin type A, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/07/2007, EC decision date: 24/10/2007, Last updated: 08/02/2008 -
List item
Referral: Bicaluplex
bicalutamide, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/09/2007, EC decision date: 22/11/2007, Last updated: 07/02/2008 -
List item
Referral: Fentanyl-ratiopharm_TTS
fentanyl, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/07/2007, EC decision date: 23/10/2007, Last updated: 14/12/2007